MX2016006915A - Aplicacion de laminina a cultivo de celulas endoteliales de la cornea. - Google Patents

Aplicacion de laminina a cultivo de celulas endoteliales de la cornea.

Info

Publication number
MX2016006915A
MX2016006915A MX2016006915A MX2016006915A MX2016006915A MX 2016006915 A MX2016006915 A MX 2016006915A MX 2016006915 A MX2016006915 A MX 2016006915A MX 2016006915 A MX2016006915 A MX 2016006915A MX 2016006915 A MX2016006915 A MX 2016006915A
Authority
MX
Mexico
Prior art keywords
corneal endothelial
present
endothelial cells
laminin
application
Prior art date
Application number
MX2016006915A
Other languages
English (en)
Spanish (es)
Inventor
Noriko Koizumi
Shigeru Kinoshita
Okumura Naoki
E Kruse Friedrich
SCHLOETZER-SCHREHARDT Ursula
Original Assignee
Kyoto Prefectural Public Univ Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoto Prefectural Public Univ Corp filed Critical Kyoto Prefectural Public Univ Corp
Publication of MX2016006915A publication Critical patent/MX2016006915A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2016006915A 2013-11-27 2014-11-26 Aplicacion de laminina a cultivo de celulas endoteliales de la cornea. MX2016006915A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013244972 2013-11-27
PCT/JP2014/081917 WO2015080297A1 (en) 2013-11-27 2014-11-26 Application of laminin to corneal endothelial cell culture

Publications (1)

Publication Number Publication Date
MX2016006915A true MX2016006915A (es) 2017-01-23

Family

ID=52432880

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016006915A MX2016006915A (es) 2013-11-27 2014-11-26 Aplicacion de laminina a cultivo de celulas endoteliales de la cornea.

Country Status (10)

Country Link
US (1) US11624053B2 (cg-RX-API-DMAC7.html)
EP (1) EP3074508B1 (cg-RX-API-DMAC7.html)
JP (3) JP6470286B2 (cg-RX-API-DMAC7.html)
CN (1) CN105814195A (cg-RX-API-DMAC7.html)
BR (1) BR112016011096A2 (cg-RX-API-DMAC7.html)
CA (1) CA2931280A1 (cg-RX-API-DMAC7.html)
ES (1) ES2763433T3 (cg-RX-API-DMAC7.html)
MX (1) MX2016006915A (cg-RX-API-DMAC7.html)
RU (1) RU2704984C1 (cg-RX-API-DMAC7.html)
WO (1) WO2015080297A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2788472T1 (sl) 2011-12-06 2019-04-30 Astellas Institute For Regenerative Medicine Način usmerjene diferencijacije, produciranja endotelijskih celic roženice
US11633477B2 (en) 2014-10-31 2023-04-25 Kyoto Prefectural Public University Corporation Treatment of cornea using laminin
EP3213761B1 (en) 2014-10-31 2021-05-19 Kyoto Prefectural Public University Corporation Novel treatment of retina using laminin
EP3375860A4 (en) * 2015-11-10 2019-07-03 Nikkiso Co., Ltd. CELL SUPPORT COMPOSITE AND METHOD FOR PRODUCING THE CELL SUPPORT COMPOSITE
JP6849957B2 (ja) * 2015-11-10 2021-03-31 国立大学法人京都大学 ラミニンフラグメント含有培地を用いる細胞培養方法
CA3052124C (en) * 2017-01-31 2024-06-25 Osaka University Method for controlling differentiation of pluripotent stem cells
WO2019079809A1 (en) * 2017-10-22 2019-04-25 The Johns Hopkins University BIOMIMETIC PLATFORMS FOR MODELING VASCULAR PHYSIOPATHOLOGY, DIAGNOSIS AND THERAPY
WO2019102593A1 (ja) * 2017-11-24 2019-05-31 株式会社Ihi 細胞培養装置
JP6664755B1 (ja) * 2018-10-02 2020-03-13 学校法人同志社 角膜内皮細胞を保存するための方法および容器
US11445723B2 (en) 2018-10-02 2022-09-20 The Doshisha Method and container for preserving corneal endothelial cells
CN113557059A (zh) * 2019-03-12 2021-10-26 日产化学株式会社 角膜疾病治疗剂
JP2023025311A (ja) * 2020-02-05 2023-02-22 味の素株式会社 タンパク質の製造方法
CN112522179A (zh) * 2020-12-23 2021-03-19 江苏艾尔康生物医药科技有限公司 一种角膜内皮细胞的分离培养方法

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678783B1 (en) 1983-11-04 1995-04-04 Asahi Chemical Ind Substituted isoquinolinesulfonyl compounds
EP1195372A1 (en) 1994-04-18 2002-04-10 Mitsubishi Pharma Corporation N-heterocyclic substituted benzamide derivatives with antihypertensive activity
JP3421217B2 (ja) 1995-11-20 2003-06-30 麒麟麦酒株式会社 Ｒｈｏ標的タンパク質Ｒｈｏキナーゼ
AU3300297A (en) 1996-06-05 1998-01-07 General Hospital Corporation, The Laminin-5 and the formation of basement membrane structure
FR2765781B1 (fr) 1997-07-08 1999-09-24 Gioia Bruno Di Procede de fabrication d'un accessoire de mode, dispositif pour la mise en oeuvre du procede et accessoire de mode ainsi realise
US6042262A (en) 1997-07-29 2000-03-28 Stryker Technologies Corportion Apparatus for storing, mixing, and dispensing two-component bone cement
US6693169B1 (en) 1998-10-13 2004-02-17 The General Hospital Corporation Laminin 5, 13 and 14 and uses thereof
AU4675300A (en) 1999-04-30 2000-11-17 Biostatum, Inc. Recombinant laminin 5
US6635616B2 (en) 2000-05-01 2003-10-21 The General Hospital Corporation Laminin 15
US6933273B2 (en) 2000-12-21 2005-08-23 Karl Tryggvason Isolated laminin 10
ATE353889T1 (de) 2001-03-23 2007-03-15 Bayer Pharmaceuticals Corp Rho-kinase inhibitoren
WO2002076976A2 (en) 2001-03-23 2002-10-03 Bayer Corporation Rho-kinase inhibitors
CN101310771B (zh) 2001-04-11 2012-08-08 千寿制药株式会社 视觉功能障碍改善剂
JPWO2002100833A1 (ja) 2001-06-12 2004-09-24 住友製薬株式会社 Ｒｈｏキナーゼ阻害剤
CA2472619A1 (en) 2002-01-10 2003-07-24 Bayer Corporation Fused pyrimidine derivates as rho-kinase inhibitors
EP1470122B1 (en) 2002-01-23 2007-12-19 Bayer Pharmaceuticals Corporation Rho-kinase inhibitors
JP2004024852A (ja) 2002-04-30 2004-01-29 Amniotec:Kk 角膜内皮様シート、及びその作製方法
AU2003211971A1 (en) * 2002-04-30 2003-11-17 Amniotec Inc. Corneal endothelium-like sheet and method of constructing the same
CA2493230A1 (en) 2002-07-22 2004-01-29 Asahi Kasei Pharma Corporation 5-substituted isoquinoline derivative
CA2400996A1 (en) 2002-09-03 2004-03-03 Lisa Mckerracher 1,4-substituted cyclohexane derivatives
US7160894B2 (en) 2003-06-06 2007-01-09 Asahi Kasei Pharma Corporation Tricyclic compound
EP1644365A2 (en) 2003-07-02 2006-04-12 Biofocus Discovery Ltd Pyrazine and pyridine derivatives as rho kinase inhibitors
WO2005039564A1 (en) 2003-10-02 2005-05-06 Vertex Pharmaceuticals Incorporated Phthalimide compounds useful as protein kinase inhibitors
US7547779B2 (en) 2003-10-06 2009-06-16 Glaxo Group Limited Preparation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors
EP1670466A4 (en) 2003-10-06 2007-04-25 Glaxo Group Ltd PREPARATION OF 1,6,7-TRISUBSTITUTED AZABENIC ZIMIDAZOLES AS KINASE-INHIBITORS
WO2005037198A2 (en) 2003-10-06 2005-04-28 Glaxo Group Limited Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors
WO2005038015A1 (en) 2003-10-10 2005-04-28 Cellular Bioengineering, Inc. Human corneal endothelial cells and methods of obtaining and culturing cells for corneal cell transplantation
CN100560142C (zh) 2003-10-10 2009-11-18 细胞生物工程公司 用于在生物聚合物上培养角膜内皮细胞和相关细胞以及产生人工角膜移植物的方法和组合物
EP1677848A2 (en) 2003-10-10 2006-07-12 Lui, Ge Ming Methods and compositions for growing corneal endothelial and related cells on biopolymers and creation of artifical corneal transplants
JP2007008816A (ja) 2003-10-15 2007-01-18 Ube Ind Ltd 新規イソキノリン誘導体
JP2007015928A (ja) 2003-10-15 2007-01-25 Ube Ind Ltd 新規オレフィン誘導体
TWI344961B (en) 2003-10-15 2011-07-11 Ube Industries Novel indazole derivative
EP4248752A3 (en) 2004-01-23 2024-01-03 President And Fellows Of Harvard College Improved modalities for the treatment of degenerative diseases of the retina
ES2532778T3 (es) 2004-02-12 2015-03-31 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Administración terapéutica del péptido antiangiogénico mezclado C16Y
JP2007523202A (ja) 2004-02-24 2007-08-16 ビオアクソン・テラプティーク・インコーポレーテッド ４置換ピペリジン誘導体
RU2006138621A (ru) 2004-04-02 2008-05-10 Вертекс Фармасьютикалз Инкорпорейтед (Us) Азаиндолы, полезные в качестве ингибиторов rock и других протеинкиназ
EP1829876A4 (en) 2004-11-26 2009-04-01 Asahi Kasei Pharma Corp NITROGENIC TRICYCLIC COMPOUND
CA2621181C (en) 2005-08-30 2011-04-19 Asahi Kasei Pharma Corporation 5-isoquinolinesulfonamide compounds
WO2007083685A1 (ja) 2006-01-19 2007-07-26 Senju Pharmaceutical Co., Ltd. 生体内で細胞増殖可能な角膜内皮製剤
US20090175835A1 (en) 2006-02-07 2009-07-09 Korea Institute Of Radiological & Medical Sciences Composition for treating damage of central or peripheral nerve system
WO2007127172A2 (en) 2006-04-27 2007-11-08 The Trustees Of Columbia University In The City Of New York Layered bio-adhesive compositions and uses thereof
US8951799B2 (en) 2007-01-04 2015-02-10 Biolamina Ab Composition and method for enabling proliferation of pluripotent stem cells
BRPI0816182A2 (pt) 2007-08-29 2015-04-14 Senju Pharma Co Agente para promoção de adesão celular endotelial corneana
US20090306772A1 (en) 2008-04-18 2009-12-10 The Regents Of The University Of California Ocular Scaffolds and Methods for Subretinal Repair of Bruch's Membrane
US8680182B2 (en) 2009-06-04 2014-03-25 Clemson University Research Foundation Methods for promoting the revascularization and reenervation of CNS lesions
WO2010140464A1 (ja) 2009-06-05 2010-12-09 国立大学法人 熊本大学 細胞の分化誘導方法
JP5590646B2 (ja) 2009-10-08 2014-09-17 国立大学法人大阪大学 ヒト多能性幹細胞用培養基材およびその利用
RU2418067C1 (ru) 2009-12-03 2011-05-10 Государственное образовательное учреждение высшего профессионального образования "Оренбургский государственный университет" Способ культивирования клеток
WO2011080984A1 (en) 2009-12-29 2011-07-07 Senju Pharmaceutical Co., Ltd. Therapeutic agent (y - 39983 ) for corneal endothelial dysfunction
CA2828794C (en) 2010-12-17 2021-07-13 Biolamina Ab Cell culture medium
WO2012173207A1 (ja) 2011-06-14 2012-12-20 独立行政法人理化学研究所 網膜細胞への分化誘導方法
JP5761827B2 (ja) 2011-07-15 2015-08-12 国立大学法人大阪大学 角膜内皮細胞の調製方法
WO2013047763A1 (ja) 2011-09-29 2013-04-04 オリエンタル酵母工業株式会社 ラミニン５１１を含んだ系で哺乳類細胞を培養する方法
IL320536A (en) 2011-11-14 2025-06-01 Astellas Inst For Regenerative Medicine Pharmaceutical preparations of human RPE cells and their use
JP5985207B2 (ja) 2011-11-25 2016-09-06 住友化学株式会社 網膜色素上皮細胞の製造方法
CA2856867C (en) 2011-11-25 2021-06-01 Sumitomo Chemical Company, Limited Methods for producing retinal tissue and retina-related cell
SI2788472T1 (sl) * 2011-12-06 2019-04-30 Astellas Institute For Regenerative Medicine Način usmerjene diferencijacije, produciranja endotelijskih celic roženice
US9351914B2 (en) 2012-03-25 2016-05-31 The Board Of Trustees Of The Leland Stanford Junior University Methods for modulating hair growth using truncated laminin-511
RS57257B1 (sr) 2012-12-03 2018-08-31 Biolamina Ab Metodi proizvodnje rpe ćelija
JP6518879B2 (ja) 2013-10-09 2019-05-29 株式会社ヘリオス 網膜色素上皮細胞の純化方法
EP3213761B1 (en) 2014-10-31 2021-05-19 Kyoto Prefectural Public University Corporation Novel treatment of retina using laminin
US11633477B2 (en) 2014-10-31 2023-04-25 Kyoto Prefectural Public University Corporation Treatment of cornea using laminin
WO2020006539A1 (en) 2018-06-29 2020-01-02 Platelet Biogenesis, Inc. Compositions for drug delivery and methods of use thereof

Also Published As

Publication number Publication date
EP3074508B1 (en) 2019-11-06
EP3074508A1 (en) 2016-10-05
WO2015080297A1 (en) 2015-06-04
CN105814195A (zh) 2016-07-27
US20170002318A1 (en) 2017-01-05
RU2704984C1 (ru) 2019-11-01
JP6470286B2 (ja) 2019-02-13
BR112016011096A2 (pt) 2017-09-19
CA2931280A1 (en) 2015-06-04
ES2763433T3 (es) 2020-05-28
JP2019054828A (ja) 2019-04-11
JP2020188778A (ja) 2020-11-26
JP2016539641A (ja) 2016-12-22
RU2016125225A (ru) 2018-01-09
US11624053B2 (en) 2023-04-11

Similar Documents

Publication Publication Date Title
MX2016006915A (es) Aplicacion de laminina a cultivo de celulas endoteliales de la cornea.
IN2015KN00666A (cg-RX-API-DMAC7.html)
MX366900B (es) Métodos y materiales para diferenciación hematoendotelial de células germinales pluripotentes humanas bajo condiciones definidas.
IL264430B (en) Method of culturing retinal pigment epithelial cells and such cells for use for increasing expression of alpha integrin subunit in the cells
SG10201704503SA (en) Culture medium composition, and method for culturing cell or tissue using said composition
MX2023001878A (es) Celulas modificadas geneticamente que comprenden un gen humano modificado de la region constante alfa del receptor de celulas t.
WO2012056109A3 (en) Plant derived cell culture material
HRP20181422T1 (hr) Mdck-derivirane stanične linije prilagođene kulturi bez seruma i suspenzijskoj kulturi te postupak proizvodnje virusa cjepiva koristeći navedene stanice
IN2014DN00203A (cg-RX-API-DMAC7.html)
WO2011130624A3 (en) Sustained polypeptide expression from synthetic, modified rnas and uses thereof
ZA201206635B (en) Cell culture medium for the growth and differentiation of cells of the hematopoietic lineage
EP3198003A4 (en) Seeding an adherent cell bioreactor with non-adherent cells increases seeding density limit and reduces required expansion time
EP4585589A3 (en) Stem cell cultures
GB2548740A (en) Methods for generation of podocytes from pluripotent stem cells and cells produced by the same
HK1218139A1 (zh) 去分化的重新編程細胞所衍生的細胞組合物
EP2995677A4 (en) Culture medium composition for improving regenerative capacity of stem cells, and stem cell culturing method using same
MX2015011781A (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
IL288819A (en) Methods for cell culture and preparations for antibody production
SG10201806083RA (en) Microcarrier perfusion culturing methods and uses thereof
MX2015010844A (es) Cultivo liquido de celulas madre epiteliales.
WO2015073625A3 (en) Synergistic genome-nonintegrating reprogramming by micrornas and transcription factors
HK1220404A1 (zh) 用於细胞培养的细胞外基质组合物珠粒
IL246525B (en) Pomegranate derived cell culture and methods for preparing and using the same
IL243634A0 (en) Method and medium for in vitro growth of stem cells
EP3693452A4 (en) CELL CULTURE CONTAINER, CELL ACQUISITION PROCESS AND CELL CULTURE PROCESS